出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年6月
IVD受託製造市場 : デバイスタイプ (消耗品、機器)、テクノロジー (免疫測定、臨床化学、分子診断、微生物学、血液学、凝固)、サービス (製造、アッセイ開発) – 2028年までの世界予測
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) – Global Forecast to 2028
| ページ数 | 211 |
| 図表数 | 204 |
| 種別 | 英文調査報告書 |
| 価格 |
The global IVD contract manufacturing market is projected to reach USD 25.5 billion by 2028 from USD 15.0 billion in 2023, at a CAGR of 11.2% during the forecast period. The high cost associated with in-house manufactured IVD products, the adoption of new technology to develop efficient products by IVD contract manufacturers, and the increased need to outsource manufacturing to CMOs by large manufacturers to reduce the manufacturing burden and focus on the development of newer technology.
There has been increased manufacturing activities and development by CMOs of advanced technological equipments to compete in this highly fragmented market and strengthen its position.
“IVD Equipment segment accounted for a larger share of the IVD contract manufacturing market”
In 2022, the IVD equipment segment accounted for a larger share of the IVD contract manufacturing market. This segment is also estimated to grow at a stable CAGR during the forecast period. Growth in this segment can primarily be attributed to the increasing volume of IVD tests performed globally and need burst of molecular test equipment post the Covid-19 pandemic.
“The molecular diagnostic segment will grow at highest CAGR during the forecast period”
Based on technology, the molecular diagnostic segment will grow at highest CAGR during the forecast period. Growth in this segment can primarily be attributed to the rising prevalence of infectious diseases, cancer, and various genetic disorders, increasing applications of molecular diagnostic technologies in pharmacogenetics and point-of-care testing. Moreover, the increasing awareness and acceptance of personalized medicine, technological advancements, and the growing application of MDx in hereditary disease testing & prenatal testing is also likely to influence the market growth. The growing use of PCR in proteomics and genomics, automation of instruments, and the emergence of advanced technologies such as qRT-PCR is also likely to support the growth of the market.
“Asia Pacific will grow at highest CAGR during the forecast period”
In 2022, Asia Pacific will grow at highest CAGR during the forecast period. Major factors driving the growth of this market are the presence of large numebr of conntract manufacturers, the rise in number of CMOs in China and India at an exobidantly high rate, the manufacturing capabilites and effienciency of the development plants in this region, ease of supply chain logistics, and cost controlled production of high quality equipments.
The break-up of the profile of primary participants in the IVD contract manufacturing market:
• By Company Type: Tier 1 – 34%, Tier 2 – 38%, and Tier 3 – 28%
• By Designation: C Level – 26%, Director Level – 35%, Others-39%
• By Region: Asia Pacific – 39%, North America – 28%, Europe –17%, Latin America – 9%
• Middle East – 7%
The prominent players in the IVD contract manufacturing market include Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada),Thermofisher (US) Savyon Diagnostics (Israel),
Research Coverage:
The report analyzes the IVD contract manufacturing market and aims at estimating the market size and future growth potential of this market based on various segments such as device type, technology, service and region. The report also includes a product portfolio matrix of various IVD contract manufactured equipment or consumables available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IVD contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
• Analysis of key drivers (high cost effective manufacturing of high technological and patented technology), restraints (risk to OEMs intellectual property and quality control), opportunities (high growth in developing countries), and challenges (shortage of skilled labour) influencing the growth of the IVD contract manufacturing market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the IVD contract manufacturing market
• Market Development: Comprehensive information on the lucrative emerging markets by type, application, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global IVD contract manufacturing market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada), Savyon Diagnostics (Israel), Thermofisher (US) in the global IVD contract manufacturing market.
目次
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKET SCOPE 28
1.3.1 MARKETS COVERED 28
FIGURE 1 IVD CONTRACT MANUFACTURING MARKET SEGMENTATION 28
FIGURE 2 IVD CONTRACT MANUFACTURING MARKET: REGIONAL SEGMENTATION 28
1.3.2 YEARS CONSIDERED 29
1.3.3 CURRENCY CONSIDERED 29
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 29
1.4 LIMITATIONS 30
1.5 STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 3 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
FIGURE 4 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 35
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END-USER, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: JABIL INC. 38
FIGURE 10 SUPPLY-SIDE ANALYSIS: IVD CONTRACT MANUFACTURING MARKET (2022) 39
FIGURE 11 DEMAND-SIDE ESTIMATION FOR IVD CONTRACT MANUFACTURING MARKET 40
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 41
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
2.2.1 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ESTIMATION 43
2.5 STUDY ASSUMPTIONS 44
2.6 LIMITATIONS & RISK ASSESSMENT 44
2.6.1 METHODOLOGY-RELATED LIMITATIONS 44
2.6.2 SCOPE-RELATED LIMITATIONS 44
2.6.3 RISK ASSESSMENT 45
TABLE 2 RISK ASSESSMENT: IVD CONTRACT MANUFACTURING MARKET 45
2.7 RECESSION IMPACT ANALYSIS 45
3 EXECUTIVE SUMMARY 46
FIGURE 15 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE,
2023 VS. 2028 (USD MILLION) 46
FIGURE 16 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE,
2023 VS. 2028 (USD MILLION) 47
FIGURE 17 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY,
2023 VS. 2028 (USD MILLION) 48
FIGURE 18 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHICAL
SNAPSHOT, 2022 49
4 PREMIUM INSIGHTS 50
4.1 IVD CONTRACT MANUFACTURING MARKET OVERVIEW 50
FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN IVD TO DRIVE MARKET 50
4.2 IVD CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS 51
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
4.3 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING
FORECAST PERIOD 52
4.4 IVD CONTRACT MANUFACTURING MARKET: REGIONAL MIX 53
FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2028 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 23 MARKET DYNAMICS: IVD CONTRACT MANUFACTURING MARKET 54
TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS 55
5.2.1 DRIVERS 55
5.2.1.1 Growing outsourcing activity by IVD manufacturers 55
5.2.1.2 High cost of in-house IVD manufacturing 56
5.2.2 RESTRAINTS 56
5.2.2.1 IP protection concerns and possibility of theft 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Growth potential of emerging economies 56
FIGURE 24 ASIA PACIFIC: HEALTHCARE EXPENDITURE, 2010–2020 (% OF GDP) 57
5.2.4 CHALLENGES 57
5.2.4.1 Lack of skilled labor 57
5.3 INDUSTRY TRENDS 57
5.3.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES 57
5.3.2 MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING 58
5.4 PORTER’S FIVE FORCES ANALYSIS 58
FIGURE 25 IVD CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 58
TABLE 4 IVD CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 59
5.4.1 THREAT OF SUBSTITUTES 59
5.4.2 BARGAINING POWER OF SUPPLIERS 59
5.4.3 INTENSITY OF COMPETITIVE RIVALRY 60
5.4.4 BARGAINING POWER OF BUYERS 60
5.4.5 THREAT OF NEW ENTRANTS 61
5.5 TARIFF AND REGULATORY LANDSCAPE 61
5.5.1 REGULATORY ANALYSIS 61
5.5.1.1 North America 61
5.5.1.1.1 US 61
TABLE 5 US: CLASSIFICATION OF MEDICAL EQUIPMENT 61
TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 62
5.5.1.1.2 Canada 62
TABLE 7 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 62
5.5.1.2 Europe 62
TABLE 8 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 63
FIGURE 26 EUROPE: IVDR TIMELINE 63
5.5.1.3 Asia Pacific 64
5.5.1.3.1 Japan 64
FIGURE 27 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN 64
TABLE 9 JAPAN: CLASSIFICATION OF IVD REAGENTS IN JAPAN 65
TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 65
5.5.1.3.2 China 65
TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 66
5.5.1.3.3 India 66
FIGURE 28 INDIA: REGULATORY PROCESS FOR IVD DEVICES 66
5.5.1.4 South Korea 66
TABLE 12 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 67
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.6 KEY CONFERENCES AND EVENTS IN 2022–2023 70
TABLE 18 IVD CONTRACT MANUFACTURING MARKET: DETAILED LIST OF
CONFERENCES AND EVENTS 70
5.7 PATENT ANALYSIS 71
5.7.1 PATENT PUBLICATION TRENDS FOR IVD DEVICES 71
FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2013–JULY 2023) 71
5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 71
FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR IVD DEVICES PATENTS (JANUARY 2013–JULY 2023) 72
FIGURE 31 TOP 10 APPLICANT COUNTRIES/REGIONS FOR IVD DEVICES PATENTS (JANUARY 2013–JULY 2023) 72
5.7.3 PATENT PUBLICATION TRENDS FOR IVD DEVICES 73
TABLE 19 IVD DEVICES: LIST OF MAJOR PATENTS 73
5.8 TECHNOLOGY ANALYSIS 74
5.8.1 KEY TECHNOLOGIES: IVD CONTRACT MANUFACTURING MARKET 74
5.8.2 ADJACENT TECHNOLOGIES 75
5.9 SUPPLY CHAIN ANALYSIS 76
FIGURE 32 IVD CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2022) 76
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 76
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IVD PRODUCTS 76
5.10.2 BUYING CRITERIA 77
FIGURE 34 KEY BUYING CRITERIA FOR IVD PRODUCTS 77
TABLE 20 KEY BUYING CRITERIA FOR IVD PRODUCTS 77
5.11 ECOSYSTEM ANALYSIS 78
FIGURE 35 IVD CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS (2022) 78
5.12 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS 78
FIGURE 36 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS 78
5.13 IVD CONTRACT MANUFACTURING MARKET: RECESSION IMPACT 79
6 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE 80
6.1 INTRODUCTION 81
TABLE 21 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE,
2021–2028 (USD MILLION) 81
6.2 CONSUMABLES 81
6.2.1 CONSUMABLES TO DOMINATE IVD CONTRACT MANUFACTURING MARKET 81
TABLE 22 IVD CONTRACT MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 82
6.3 EQUIPMENT 82
6.3.1 AUTOMATION, ADVANCEMENTS, AND EMPHASIS ON EFFICIENT DIAGNOSTICS TO DRIVE MARKET 82
TABLE 23 IVD CONTRACT MANUFACTURING MARKET FOR EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 83
7 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY 84
7.1 INTRODUCTION 85
TABLE 24 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 85
7.2 IMMUNOASSAYS 85
7.3 RISING PREVALENCE OF CANCER TO DRIVE GROWTH 85
TABLE 25 IVD CONTRACT MANUFACTURING MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 86
7.4 CLINICAL CHEMISTRY 86
7.4.1 GROWING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE DEMAND FOR CLINICAL CHEMISTRY ASSAY TESTING 86
TABLE 26 IVD CONTRACT MANUFACTURING MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION) 87
7.5 MOLECULAR DIAGNOSTICS 87
7.5.1 TECHNOLOGICAL INNOVATION IN PCR TESTING TO BOOST GROWTH 87
TABLE 27 IVD CONTRACT MANUFACTURING MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.6 HEMATOLOGY 89
7.6.1 RISING ADOPTION OF AUTOMATED HEMATOLOGY ANALYZERS TO DRIVE MARKET 89
TABLE 28 IVD CONTRACT MANUFACTURING MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 89
7.7 MICROBIOLOGY 90
7.7.1 RISING PREVALENCE OF MICROBIAL INFECTIONS TO DRIVE MARKET 90
TABLE 29 IVD CONTRACT MANUFACTURING MARKET FOR MICROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 90
7.8 COAGULATION & HEMOSTASIS 91
7.8.1 GROWING USE OF ANTICOAGULATION THERAPY IN SURGICAL PROCEDURES TO DRIVE MARKET 91
TABLE 30 IVD CONTRACT MANUFACTURING MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2021–2028 (USD MILLION) 91
7.9 OTHER TECHNOLOGIES 92
TABLE 31 IVD CONTRACT MANUFACTURING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 92
8 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE 93
8.1 INTRODUCTION 94
TABLE 32 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 94
8.2 MANUFACTURING SERVICES 94
8.2.1 MANUFACTURING SERVICES TO HOLD LARGEST MARKET SHARE TILL 2028 94
TABLE 33 MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
8.3 ASSAY DEVELOPMENT 96
8.3.1 LOW-COST SETUP, EFFICIENCY, AND HIGH THROUGHPUT TO DRIVE DEMAND FOR ASSAY DEVELOPMENT 96
TABLE 34 ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
8.4 OTHER SERVICES 98
TABLE 35 OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
9 IVD CONTRACT MANUFACTURING MARKET, BY REGION 99
9.1 INTRODUCTION 100
FIGURE 37 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 100
TABLE 36 IVD CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 101
9.2 ASIA PACIFIC 101
9.2.1 ASIA PACIFIC: RECESSION IMPACT 101
FIGURE 38 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET SNAPSHOT 102
TABLE 37 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 38 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 103
TABLE 39 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 104
TABLE 40 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 104
9.2.2 CHINA 104
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market 104
TABLE 41 CHINA: KEY MACROINDICATORS 105
TABLE 42 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 105
TABLE 43 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 106
TABLE 44 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 106
9.2.3 JAPAN 107
9.2.3.1 Universal healthcare reimbursement policies to propel market 107
TABLE 45 JAPAN: KEY MACROINDICATORS 107
TABLE 46 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 107
TABLE 47 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 108
TABLE 48 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 108
9.2.4 INDIA 108
9.2.4.1 Rising contract manufacturing capabilities to support growth 108
TABLE 49 INDIA: KEY MACROINDICATORS 109
TABLE 50 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 109
TABLE 51 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 109
TABLE 52 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 110
9.2.5 AUSTRALIA 110
9.2.5.1 Need for advanced medical and diagnostic tools to fuel growth 110
TABLE 53 AUSTRALIA: KEY MACROINDICATORS 111
TABLE 54 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 111
TABLE 55 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 111
TABLE 56 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 112
9.2.6 SOUTH KOREA 112
9.2.6.1 Rising spending on innovative IVD technologies to support market growth 112
TABLE 57 SOUTH KOREA: KEY MACROINDICATORS 113
TABLE 58 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 113
TABLE 59 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 113
TABLE 60 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 114
9.2.7 REST OF ASIA PACIFIC 114
TABLE 61 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 114
TABLE 62 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 115
TABLE 63 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 115
9.3 NORTH AMERICA 115
9.3.1 NORTH AMERICA: RECESSION IMPACT 116
TABLE 64 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 65 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 116
TABLE 66 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 117
TABLE 67 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 117
9.3.2 US 118
9.3.2.1 Increasing in-house manufacturing costs to encourage shift to contract manufacturing 118
TABLE 68 US: KEY MACROINDICATORS 118
TABLE 69 US: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 118
TABLE 70 US: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 119
TABLE 71 US: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 119
9.3.3 CANADA 120
9.3.3.1 Strong presence of key contract manufacturing companies to drive market 120
TABLE 72 CANADA: KEY MACROINDICATORS 120
TABLE 73 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 120
TABLE 74 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 121
TABLE 75 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 121
9.4 EUROPE 122
9.4.1 EUROPE: RECESSION IMPACT 122
TABLE 76 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 77 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 123
TABLE 78 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 124
TABLE 79 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
9.4.2 GERMANY 125
9.4.2.1 Germany to hold largest market share 125
TABLE 80 GERMANY: KEY MACROINDICATORS 125
TABLE 81 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 125
TABLE 82 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 126
TABLE 83 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
9.4.3 FRANCE 127
9.4.3.1 Increasing government pressure to reduce healthcare costs and budgetary constraints 127
TABLE 84 FRANCE: KEY MACROINDICATORS 127
TABLE 85 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 127
TABLE 86 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 128
TABLE 87 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
9.4.4 UK 129
9.4.4.1 Risng adoption of genome-based testing and increasing accessibility of IVD 129
TABLE 88 UK: KEY MACROINDICATORS 129
TABLE 89 UK: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 129
TABLE 90 UK: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 130
TABLE 91 UK: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 130
9.4.5 ITALY 131
9.4.5.1 Rising incidence of chronic illnesses to drive market 131
TABLE 92 ITALY: KEY MACROINDICATORS 131
TABLE 93 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 132
TABLE 94 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 132
TABLE 95 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
9.4.6 SPAIN 133
9.4.6.1 Increasing adoption of home-use medical devices to drive market 133
TABLE 96 SPAIN: KEY MACROINDICATORS 133
TABLE 97 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 134
TABLE 98 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 134
TABLE 99 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 135
9.4.7 REST OF EUROPE 135
TABLE 100 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 135
TABLE 101 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 136
TABLE 102 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136
9.5 LATIN AMERICA 136
9.5.1 LATIN AMERICA: RECESSION IMPACT 137
TABLE 103 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 104 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 137
TABLE 105 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 138
TABLE 106 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 138
9.5.2 MEXICO 138
9.5.2.1 Mexico to hold largest share of Latin American market 138
TABLE 107 MEXICO: KEY MACROINDICATORS 139
TABLE 108 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 139
TABLE 109 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 139
TABLE 110 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
9.5.3 BRAZIL 140
9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to drive market 140
TABLE 111 BRAZIL: KEY MACROINDICATORS 141
TABLE 112 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 141
TABLE 113 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 141
TABLE 114 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 142
9.5.4 REST OF LATIN AMERICA 142
TABLE 115 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 143
TABLE 116 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 143
TABLE 117 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 144
9.6 MIDDLE EAST & AFRICA 144
9.6.1 GROWING HEALTHCARE INVESTMENTS AND INFRASTRUCTURAL IMPROVEMENTS TO DRIVE MARKET 144
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 145
TABLE 118 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 145
TABLE 119 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 145
TABLE 120 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 146
10 COMPETITIVE LANDSCAPE 147
10.1 OVERVIEW 147
10.2 KEY STRATEGIES ADOPTED BY PLAYERS 147
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 148
FIGURE 39 TOP MARKET PLAYERS DOMINATE IVD CONTRACT MANUFACTURING MARKET 149
10.4 MARKET SHARE ANALYSIS 149
FIGURE 40 IVD CONTRACT MANUFACTURING MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2022 150
10.5 COMPANY EVALUATION MATRIX, 2022 150
10.5.1 STARS 151
10.5.2 EMERGING LEADERS 151
10.5.3 PERVASIVE PLAYERS 151
10.5.4 PARTICIPANTS 151
FIGURE 41 IVD CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT (2022) 152
10.6 COMPETITIVE BENCHMARKING 153
TABLE 121 OVERALL COMPANY FOOTPRINT 153
TABLE 122 OMPANY FOOTPRINT ANALYSIS, BY PRODUCT TYPE 154
TABLE 123 COMPANY FOOTPRINT ANALYSIS, BY SERVICE TYPE 155
TABLE 124 COMPANY FOOTPRINT ANALYSIS, BY REGION 156
10.7 COMPETITIVE SCENARIO 157
10.7.1 PRODUCT LAUNCHES 157
TABLE 125 PRODUCT LAUNCHES (JANUARY 2020–MAY 2023) 157
10.7.2 DEALS 157
TABLE 126 DEALS (JANUARY 2020–MAY 2023) 157
10.7.3 OTHER DEVELOPMENTS 158
TABLE 127 OTHER DEVELOPMENTS (JANUARY 2020–MAY 2023) 158
11 COMPANY PROFILES 159
11.1 KEY PLAYERS 159
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 JABIL INC. 159
TABLE 128 JABIL INC.: COMPANY OVERVIEW 159
FIGURE 42 JABIL INC.: COMPANY SNAPSHOT (2022) 160
11.1.2 SANMINA CORPORATION 163
TABLE 129 SANMINA CORPORATION: COMPANY OVERVIEW 163
FIGURE 43 SANMINA CORPORATION: COMPANY SNAPSHOT (2022) 164
11.1.3 TE CONNECTIVITY 166
TABLE 130 TE CONNECTIVITY: COMPANY OVERVIEW 166
FIGURE 44 TE CONNECTIVITY: COMPANY SNAPSHOT (2022) 167
11.1.4 CELESTICA, INC. 169
TABLE 131 CELESTICA, INC.: COMPANY OVERVIEW 169
FIGURE 45 CELESTICA, INC.: COMPANY SNAPSHOT (2022) 170
11.1.5 WEST PHARMACEUTICAL SERVICES, INC. 172
TABLE 132 WEST PHARMACEUTICALS SERVICES, INC.: COMPANY OVERVIEW 172
FIGURE 46 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022) 173
11.1.6 SAVYON DIAGNOSTICS, LTD. 175
TABLE 133 SAVYON DIAGNOSTICS, LTD.: COMPANY OVERVIEW 175
11.1.7 KMC SYSTEMS 177
TABLE 134 KMC SYSTEMS: COMPANY OVERVIEW 177
FIGURE 47 ELBIT SYSTEMS: COMPANY SNAPSHOT (2022) 177
11.1.8 CENOGENICS CORPORATION 179
TABLE 135 CENOGENICS CORPORATION: COMPANY OVERVIEW 179
11.1.9 NOVA BIOMEDICAL 180
TABLE 136 NOVA BIOMEDICAL: COMPANY OVERVIEW 180
11.1.10 CONE BIOPRODUCTS 182
TABLE 137 CORE BIOPRODUCTS: COMPANY OVERVIEW 182
11.1.11 INVETECH 183
TABLE 138 INVETECH: COMPANY OVERVIEW 183
FIGURE 48 FORTIVE: COMPANY SNAPSHOT (2022) 183
11.1.12 AVIOQ, INC. 185
TABLE 139 AVIOQ, INC.: COMPANY OVERVIEW 185
11.1.13 MERIDIAN BIOSCIENCE, INC. 187
TABLE 140 MERIDIAN BIOSCIENCE, INC.: COMPANY OVERVIEW 187
FIGURE 49 MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT (2022) 187
11.1.14 KIMBALL ELECTRONICS, INC. 189
TABLE 141 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW 189
FIGURE 50 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2022) 190
11.1.15 NEMERA 192
TABLE 142 NEMERA: COMPANY OVERVIEW 192
11.1.16 VIANT MEDICAL HOLDINGS, INC. 193
TABLE 143 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW 193
11.1.17 PHILLIPS-MEDISIZE CORPORATION 194
TABLE 144 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW 194
11.1.18 NOLATO GW, INC. 196
TABLE 145 NOLATO GW, INC.: COMPANY OVERVIEW 196
FIGURE 51 NOLATO GW, INC.: COMPANY SNAPSHOT (2022) 197
11.1.19 STRATEC SE 199
TABLE 146 STRATEC SE: COMPANY OVERVIEW 199
FIGURE 52 STRATEC SE: COMPANY SNAPSHOT (2022) 199
11.1.20 THERMO FISHER SCIENTIFIC, INC. 201
TABLE 147 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 201
FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 202
11.1.21 FUJIREBIO 204
TABLE 148 FUJIREBIO: COMPANY OVERVIEW 204
FIGURE 54 H.U. GROUP: COMPANY SNAPSHOT (2022) 204
11.1.22 BIOKIT (WERFEN) 206
TABLE 149 BIOKIT: COMPANY OVERVIEW 206
FIGURE 55 WERFEN: COMPANY SNAPSHOT (2022) 206
11.2 OTHER COMPANIES 208
11.2.1 AFFINITY LIFESCIENCE 208
11.2.2 SEKISUI 208
11.2.3 PRESTIGE DIAGNOSTICS 209
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 210
12.1 DISCUSSION GUIDE 210
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 214
12.3 CUSTOMIZATION OPTIONS 216
12.4 RELATED REPORTS 216
12.5 AUTHOR DETAILS 217